Back
Cytek Biosciences Stock Price Chart
Sell
16
CTKB
Cytek Biosciences
Last Price:
6.10
Seasonality Move:
42.11%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTKB is experiencing slight buying pressure.
Cytek Biosciences Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.2 | Sell |
| 20-day SMA: | 6.1 | Buy |
| 50-day SMA: | 6.36 | Sell |
| 200-day SMA: | 7.03 | Sell |
| 8-day EMA: | 6.18 | Sell |
| 20-day EMA: | 6.19 | Sell |
| 50-day EMA: | 6.49 | Sell |
| 200-day EMA: | 7.43 | Sell |
Cytek Biosciences Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 45.69 | Sell |
| Chaikin Money Flow: | 56899 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.85 - 6.29) | Buy |
| Bollinger Bands (100): | (6.26 - 8.48) | Sell |
Cytek Biosciences Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cytek Biosciences Stock
Is Cytek Biosciences Stock a Buy?
- Cytek Biosciences share price is 6.10 while CTKB 8-day simple moving average is 6.20, which is a Sell signal.
- The stock price of CTKB is 6.10 while Cytek Biosciences 20-day SMA is 6.10, which makes it a Buy.
- Cytek Biosciences 50-day simple moving average is 6.36 while CTKB share price is 6.10, making it a Sell technically.
- CTKB stock price is 6.10 and Cytek Biosciences 200-day simple moving average is 7.03, creating a Sell signal.
CTKB Technical Analysis vs Fundamental Analysis
Sell
16
Cytek Biosciences (CTKB)
is a Sell
Is Cytek Biosciences a Buy or a Sell?
-
Cytek Biosciences stock is rated a Sell
The current Cytek Biosciences [CTKB] share price is $6.10. The Score for CTKB is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
Cytek Biosciences Stock Info
Market Cap:
800.76M
Price in USD:
6.10
Share Volume:
560.86K
Cytek Biosciences 52-Week Range
52-Week High:
9.87
52-Week Low:
3.80
Sell
16
Cytek Biosciences (CTKB)
is a Sell
Cytek Biosciences Share Price Forecast
-
What is the Cytek Biosciences stock price today?
The Cytek Biosciences stock price is 6.10 USD today. -
Will CTKB stock go up or go down?
Cytek Biosciences> share price is forecast to RISE/FALL based on technical indicators -
Is Cytek Biosciences overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cytek Biosciences is overvalued.
Is Cytek Biosciences Stock a Buy?
- Cytek Biosciences share price is 6.10 while CTKB 8-day exponential moving average is 6.18, which is a Sell signal.
- The stock price of CTKB is 6.10 while Cytek Biosciences 20-day EMA is 6.19, which makes it a Sell.
- Cytek Biosciences 50-day exponential moving average is 6.49 while CTKB share price is 6.10, making it a Sell technically.
- CTKB stock price is 6.10 and Cytek Biosciences 200-day simple moving average is 7.43, creating a Sell signal.
Fundamental Analysis of Cytek Biosciences
Is Cytek Biosciences a good investment?
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.04 per share, an increase this year of $0.06 per share, and an increase next year of $0.08 per share.
Technical Analysis of Cytek Biosciences
Should I short Cytek Biosciences stock?
- CTKB Moving Average Covergence Divergence (MACD) indicator is -0.05, suggesting Cytek Biosciences is a Sell
- Cytek Biosciences Relative Strength Index (RSI) is 45.69, which suggest Cytek Biosciences is oversold
- The Bollinger Bands (25) for Cytek Biosciences is (5.85 - 6.29), which suggest Cytek Biosciences is a Sell
- The Bollinger Bands (100) for Cytek Biosciences is (6.26 - 8.48), which suggest Cytek Biosciences is a Sell
* Cytek Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.